Cargando…
Hemodynamic Effects of Protamine Infusion in Dogs with Myxomatous Mitral Valve Disease Undergoing Mitral Valvuloplasty
Protamine, an antagonizing agent to heparin, is indispensable for dogs undergoing cardiopulmonary bypass. Protamine-induced hypotension (PIH) during cardiac anesthesia has been reported in humans. The purpose of this study was to describe the hemodynamic effect of protamine administration in dogs du...
Autores principales: | Yoshida, Tomohiko, Matsuura, Katsuhiro, Mandour, Ahmed S., Aboshi, Yuki, Yamada, Shusaku, Yotsuida, Hideki, Hasegawa, Mizuki, Cheng, Chieh-Jen, Yaginuma, Youta, Watanabe, Momoko, Fukuzumi, Shou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031179/ https://www.ncbi.nlm.nih.gov/pubmed/35448675 http://dx.doi.org/10.3390/vetsci9040178 |
Ejemplares similares
-
Surgical treatment for left atrial rupture due to myxomatous mitral valve disease in three dogs: A case report
por: Yoshida, Tomohiko, et al.
Publicado: (2022) -
Mitral valvuloplasty with left atrial appendage closure and pacemaker implantation in a dog with severe myxomatous mitral valve degeneration: a case report
por: Yoshida, Tomohiko, et al.
Publicado: (2022) -
Measurement of Pulmonary Artery Wave Reflection Before and After Mitral Valvuloplasty in Canine Patients With Pulmonary Hypertension Caused by Myxomatous Mitral Valve Disease
por: Yoshida, Tomohiko, et al.
Publicado: (2021) -
Changes in renin‐angiotensin‐aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs
por: Cheng, Chieh‐Jen, et al.
Publicado: (2022) -
Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)